eMed announces successful completion of the previously announced tender offer by its wholly-owned subsidiary. Science 37 Holdings, Inc. (NASDAQ: SNCE) ("Science 37') will cease to be traded on the NASDAQ Capital Market. This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements.